+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

False positivity of the Aspergillus galactomannan Platelia ELISA because of piperacillin/tazobactam treatment: does it represent a clinical problem?



False positivity of the Aspergillus galactomannan Platelia ELISA because of piperacillin/tazobactam treatment: does it represent a clinical problem?



Journal of Antimicrobial ChemoTherapy 62(5): 1109-1112



Objectives: False-positive results of the galactomannan (GM) ELISA caused by concurrent administration of piperacillin/tazobactam have been reported in patients with febrile neutropenia. Patients and methods: This prospective study investigated different sampling times in 30 patients receiving piperacillin/tazobactam for febrile neutropenia.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 031417379

Download citation: RISBibTeXText

PMID: 18647743

DOI: 10.1093/jac/dkn308


Related references

False-positive results in the galactomannan Platelia™ Aspergillus assay with generic piperacillin/tazobactam. Revista Iberoamericana de Micologia 2019, 2019

False-positive galactomannan platelia Aspergillus test results for patients receiving piperacillin-tazobactam. Clinical Infectious Diseases 38(6): 913-916, 2004

False positive galactomannan Platelia due to piperacillin-tazobactam. Medecine et Maladies Infectieuses 42(1): 10-14, 2012

Reactivity of platelia Aspergillus galactomannan antigen with piperacillin-tazobactam: clinical implications based on achievable concentrations in serum. Antimicrobial Agents and ChemoTherapy 48(6): 1989-1992, 2004

Lack of evidence that false-positive Aspergillus galactomannan antigen test results are due to treatment with piperacillin-tazobactam. Clinical Infectious Diseases 39(9): 1401-2; Author Reply 1402-3, 2004

Treatment with piperacillin-tazobactam and false-positive Aspergillus galactomannan antigen test results for patients with hematological malignancies. Clinical Infectious Diseases 38(6): 917-920, 2004

Generic piperacillin/tazobactam is not associated with galactomannan false-positivity in adult patients with cancer: a case-control study. European Journal of Clinical Microbiology and Infectious Diseases 34(7): 1437-1441, 2016

False positivity for Aspergillus antigenemia related to the administration of piperacillin/tazobactam. European Journal of Internal Medicine 16(7): 489-491, 2005

Reduction in false-positive Aspergillus serum galactomannan enzyme immunoassay results associated with use of piperacillin-tazobactam in the United States. Journal of Clinical Microbiology 52(6): 2199-2201, 2015

Treatment with piperacillin-tazobactam and Aspergillus galactomannan test results for patients with hematological malignancies. European Journal of Internal Medicine 18(1): 79, 2007

The interaction between piperacillin-tazobactam and Aspergillus galactomannan antigenemia assay: is the story over?. Infection 41(1): 293-294, 2013

Piperacillin/tazobactam (Tazocin™) seems to be no longer responsible for false-positive results of the galactomannan assay. Journal of Antimicrobial ChemoTherapy 67(7): 1746-1748, 2012

False positive galactomannan results in adult hematological patients treated with piperacillin-tazobactam. Revista Iberoamericana de Micologia 24(2): 106-112, 2007

False-positive results by the platelia Aspergillus galactomannan antigen test for patients treated with amoxicillin-clavulanate. Clinical and Vaccine Immunology 15(7): 1132-1133, 2008

Assessing the risk of false positive serum galactomannan among patients receiving piperacillin/tazobactam for febrile neutropenia. Medical Mycology 55(5): 535-540, 2016